Posted: 11 June 2025 The Company: The client of our BioMelbourne Network member mexec, is a biotechnology company with a unique, world-leading platform technology enabling site-specific drug delivery. This patented technology can be engineered into various product forms,…
Posted: 4 June 2025 The Company: The Aikenhead Centre for Medical Discovery (ACMD) is a collaborative biomedical engineering centre accelerating the translation and commercialisation of research. The ACMD brings together clinicians, major universities, leading research institutions, and…
Posted: 4 June 2025 The Company: PureCDM is dedicated to providing a full range of expert biostatistical support to clients in the pharmaceutical, biotechnology, and MedTech industries. Our mission is to break down the complexities of data,…
Posted: 29 May 2025 The Company: The client of our BioMelbourne Network member mexec, is a Melbourne-based, ASX-listed medical device company transforming nerve repair and improving patient outcomes. They have developed a unique approach to nerve replacement by…
Posted 27 May 2025 The Company: Cencora Pharmalex is one of the leading service providers for the Pharmaceutical Industry globally and is specialised in all aspects of drugs and medical devices approval, of the market development and any…
Posted: 15 May 2025 The Company CommercialEyes is Australia’s leading pharmaceutical and medical device commercialisation company, with over 23 years of experience and a team of over 100 experts. They provide tailored, high-quality solutions to…
Posted: 15 May 2025 The Company Our client is a global leader in microscopic imaging, with patented technologies enabling in vivo imaging of tissues across a wide range of surgical and research applications. Through innovation and collaborations locally…
Posted: 15 May 2025 The Company Our client is a medical device company dedicated to developing cutting-edge products from their clinically supported technology platform. By increasing patient adherence to prescribed medications, they hope to reduce hospitalisations and improve…
Posted: 30 April 2025 The Company Our client is an ASX-listed biotechnology company developing a novel, best-in-class neuroprotective therapeutic. With an expert team around Australia, they are currently working on a Phase II clinical trial with a view…
Posted: 22 April 2025 The Company Our Client partners with pharmaceutical and biotechnology enterprises, research organisations, university partners and medtech companies from around the world to bring new therapies to market. Their experienced team provides specialist trial services…
Posted: 14 April 2025 The Company Our client is an Australian owned, private company specialising in the provision of Clinical Data Management services and deployment of eClinical solutions. The Opportunity As a Consultant Biostatistician, your role will be…
Posted: 21 March 2025 The Company Our client is an ASX-listed drug development company working to advance new treatments for cancer and fibrotic diseases. With multiple assets in their pipelines, their team is currently working across several studies…